Welcome to Scientific Depth, i3's online information center that includes access to:

The Innovation Series

Articles, white papers and presentations that provide insight into the science and business of clinical research.

i3 InLine

Current and back issues of our monthly newsletter that presents unique i3 insights plus a summary of the top news impacting the pharma industry.

Engage

Current and back issues of our online newsletter offering timely insight into career matters, hiring practices, and workplace trends for clinical research professionals.

i3 Articles and White Papers

Published work and thought papers written by i3 specialists.

Case Studies

Reports on the results our clients have obtained by drawing on the specialized expertise of i3 scientists, researchers, and associated professionals, or from the use of our data products.

Scientific Presentations and Posters

Login or sign up now to gain access.

i3 InLine Spotlight Article:

Adaptive Design Can Reduce Time to Market, Lower Development Costs

With statistics showing that roughly 50 percent of Phase 3 study drugs never reach the market and financial and economic pressures limiting product development funding, clinical trial sponsors are giving new consideration to an approach that would allow them to evaluate interim data and either make mid-trial adjustments to move the study toward market approval or cut their losses and put their resources elsewhere.

Read the entire article

Sign up now for access to the entire brief!

June 24, 2010
Source: i3 InLine